{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:15:33Z","timestamp":1793985333040,"version":"4.8.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1245\/s10434-019-08178-x","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T14:02:42Z","timestamp":1578664962000},"page":"1900-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Elevated Serum \u03b1-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative Resection"],"prefix":"10.1245","volume":"27","author":[{"given":"James D.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie L.","family":"Shindorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim Y.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton V.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah L.","family":"Deneve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"2","key":"8178_CR1","first-page":"168","volume":"91","author":"HA Edmondson","year":"1956","unstructured":"Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child. 1956;91(2):168\u201386.","journal-title":"AMA J Dis Child"},{"issue":"2","key":"8178_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S","volume":"46","author":"JR Craig","year":"1980","unstructured":"Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46(2):372\u201379.","journal-title":"Cancer"},{"issue":"6","key":"8178_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2012.08.001","volume":"215","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Mayo SC, Hyder O, et al. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215(6):820\u201330.","journal-title":"J Am Coll Surg"},{"key":"8178_CR4","first-page":"151","volume":"2","author":"KJ Lafaro","year":"2015","unstructured":"Lafaro KJ, Pawlik TM. Fibrolamellar hepatocellular carcinoma: current clinical perspectives. J Hepatocell Carcinoma. 2015;2:151\u201357.","journal-title":"J Hepatocell Carcinoma"},{"issue":"4","key":"8178_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/jso.23658","volume":"110","author":"RT Groeschl","year":"2014","unstructured":"Groeschl RT, Miura JT, Wong RK, et al. Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. J Surg Oncol. 2014;110(4):412\u201315.","journal-title":"J Surg Oncol"},{"issue":"3","key":"8178_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/hep.20096","volume":"39","author":"HB El-Serag","year":"2004","unstructured":"El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39(3):798\u201303.","journal-title":"Hepatology"},{"issue":"2","key":"8178_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jamcollsurg.2013.10.011","volume":"218","author":"SC Mayo","year":"2014","unstructured":"Mayo SC, Mavros MN, Nathan H, et al. Treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma: a national perspective. J Am Coll Surg. 2014;218(2):196\u201305.","journal-title":"J Am Coll Surg"},{"issue":"282","key":"8178_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc. 1958;53(282):457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"8178_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B (Methodol). 1972;34(2):187\u201320.","journal-title":"J R Stat Soc Ser B (Methodol)"},{"issue":"1","key":"8178_CR10","first-page":"3","volume":"6","author":"CS Ang","year":"2013","unstructured":"Ang CS, Kelley RK, Choti MA, et al. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res. 2013;6(1):3\u20139.","journal-title":"Gastrointest Cancer Res."},{"issue":"10","key":"8178_CR11","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s11605-016-3216-x","volume":"20","author":"S Yamashita","year":"2016","unstructured":"Yamashita S, Vauthey JN, Kaseb AO, et al. Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma. J Gastrointest Surg. 2016;20(10):1725\u2013731.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"8178_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.21037\/jgo.2019.01.35","volume":"10","author":"S Chakrabarti","year":"2019","unstructured":"Chakrabarti S, Tella SH, Kommalapati A, et al. Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma. J Gastrointest Oncol. 2019;10(3):554\u2013561.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"8178_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpedsurg.2014.10.039","volume":"50","author":"DG Darcy","year":"2015","unstructured":"Darcy DG, Malek MM, Kobos R, et al. Prognostic factors in fibrolamellar hepatocellular carcinoma in young people. J Pediatr Surg. 2015;50(1):153\u201356.","journal-title":"J Pediatr Surg"},{"issue":"4","key":"8178_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000354698","volume":"85","author":"AO Kaseb","year":"2013","unstructured":"Kaseb AO, Shama M, Sahin IH, et al. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. Oncology. 2013;85(4):197\u201303.","journal-title":"Oncology"},{"issue":"7","key":"8178_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/jso.24742","volume":"116","author":"JP Silva","year":"2017","unstructured":"Silva JP, Gorman RA, Berger NG, et al. The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. J Surg Oncol. 2017;116(7):831\u201340.","journal-title":"J Surg Oncol"},{"issue":"3","key":"8178_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1245\/s10434-013-3357-z","volume":"21","author":"S Blank","year":"2014","unstructured":"Blank S, Wang Q, Fiel MI, et al. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal. Ann Surg Oncol. 2014;21(3):986\u201394.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-08178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-08178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T23:51:41Z","timestamp":1722297101000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-08178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["8178"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-08178-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"James D. McDonald, Shreya Gupta, Mackenzie L. Shindorf, Lauren A. Gamble, Samantha M. Ruff, Justin Drake, Theo Heller, Jim Y. Wan, Paxton V. Dickson, Evan S. Glazer, Jeremy L. Davis, Jeremiah L. Deneve, Jonathan M. Hernandez declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}